| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.5 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |